Contiguous Stage II Adult Burkitt Lymphoma Terminated Phase 1 / 2 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0030485 (Contiguous Stage II Adult Burkitt Lymphoma)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00288067Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaTreatment